Trillium Asset Management LLC cut its stake in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 15.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 91,111 shares of the company's stock after selling 16,536 shares during the period. Trillium Asset Management LLC owned 0.20% of Vital Farms worth $2,776,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Wellington Management Group LLP raised its stake in shares of Vital Farms by 417.8% in the fourth quarter. Wellington Management Group LLP now owns 2,431,024 shares of the company's stock worth $91,625,000 after buying an additional 1,961,550 shares during the period. Principal Financial Group Inc. raised its stake in Vital Farms by 3.2% during the 1st quarter. Principal Financial Group Inc. now owns 1,209,564 shares of the company's stock valued at $36,855,000 after purchasing an additional 37,614 shares during the period. Lord Abbett & CO. LLC boosted its position in shares of Vital Farms by 64.6% during the 4th quarter. Lord Abbett & CO. LLC now owns 1,058,753 shares of the company's stock valued at $39,904,000 after acquiring an additional 415,614 shares during the last quarter. Emerald Advisers LLC boosted its holdings in shares of Vital Farms by 13.2% in the 1st quarter. Emerald Advisers LLC now owns 978,197 shares of the company's stock worth $29,806,000 after purchasing an additional 113,874 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Vital Farms by 7.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 901,537 shares of the company's stock worth $33,978,000 after purchasing an additional 59,397 shares during the period. 98.59% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other Vital Farms news, CFO Thilo Wrede sold 1,200 shares of Vital Farms stock in a transaction on Friday, July 11th. The stock was sold at an average price of $38.97, for a total value of $46,764.00. Following the sale, the chief financial officer owned 56,187 shares in the company, valued at $2,189,607.39. The trade was a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Matthew Ohayer sold 30,000 shares of Vital Farms stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $39.17, for a total value of $1,175,100.00. Following the completion of the sale, the insider directly owned 6,858,890 shares of the company's stock, valued at $268,662,721.30. The trade was a 0.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 94,105 shares of company stock worth $3,645,398. 21.30% of the stock is owned by corporate insiders.
Vital Farms Stock Performance
NASDAQ:VITL remained flat at $47.75 during trading hours on Friday. 846,038 shares of the company's stock were exchanged, compared to its average volume of 994,887. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.10 and a current ratio of 2.48. The stock has a fifty day moving average of $37.73 and a 200-day moving average of $35.05. The firm has a market cap of $2.13 billion, a price-to-earnings ratio of 42.63 and a beta of 0.94. Vital Farms, Inc. has a 52 week low of $27.91 and a 52 week high of $48.26.
Vital Farms (NASDAQ:VITL - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.27 by $0.09. Vital Farms had a return on equity of 18.40% and a net margin of 7.84%. The business had revenue of $184.77 million during the quarter, compared to analysts' expectations of $170.28 million. During the same quarter in the prior year, the firm earned $0.36 earnings per share. The business's revenue was up 25.4% compared to the same quarter last year. As a group, research analysts anticipate that Vital Farms, Inc. will post 1.11 EPS for the current year.
Analyst Ratings Changes
A number of brokerages recently issued reports on VITL. Stifel Nicolaus raised their price target on Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Mizuho raised their price target on Vital Farms from $45.00 to $53.00 and gave the stock an "outperform" rating in a research note on Monday. DA Davidson raised their price target on Vital Farms from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Monday. Telsey Advisory Group raised their price target on Vital Farms from $46.00 to $50.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. Finally, BMO Capital Markets reissued an "outperform" rating on shares of Vital Farms in a research note on Friday, August 8th. Eleven investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $48.20.
Check Out Our Latest Analysis on Vital Farms
Vital Farms Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Further Reading

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.